Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600380'
s Operating Margin % Range Over the Past 10 Years
Min: 11.86 Med: 18.69 Max: 22.55
Current: 21
SHSE:600380's Operating Margin % is ranked better than 83.72% of 958
companies
in the Drug Manufacturers industry
Industry Median: 7.24
vs SHSE:600380: 21.00
Joincare Pharmaceutical Group Industry Co (SHSE:600380) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Joincare Pharmaceutical Group Industry Co Operating Margin % Related Terms
Joincare Pharmaceutical Group Industry Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joincare Pharmaceutical Group Industry Co Operating Margin % Chart
Joincare Pharmaceutical Group Industry Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joincare Pharmaceutical Group Industry Co Operating Margin % vs Drug Manufacturers Industry
Joincare Pharmaceutical Group Industry Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Joincare Pharmaceutical Group Industry Co (SHSE:600380) has a Operating Margin % of 26.73% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. This is 43% above median its historical median of 18.69. Over the past decade, Joincare Pharmaceutical Group Industry Co's Operating Margin % has ranged from 11.86 to 22.55. According to the industry distribution chart, Joincare Pharmaceutical Group Industry Co ranks #156 out of 958 companies in the Drug Manufacturers industry, placing it in the top 16.3%.
Is Joincare Pharmaceutical Group Industry Co's Operating Margin % too high?
Joincare Pharmaceutical Group Industry Co's current Operating Margin % of 26.73% is 43% above median its 10-year median of 18.69. Over the past 10 years, this metric has ranged from a low of 11.86 to a high of 22.55. The Drug Manufacturers industry median Operating Margin % is 7.24. Joincare Pharmaceutical Group Industry Co's value of 26.73% is 269.2% above this industry median. Based on the distribution chart, Joincare Pharmaceutical Group Industry Co ranks #156 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Joincare Pharmaceutical Group Industry Co has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Joincare Pharmaceutical Group Industry Co's Operating Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Joincare Pharmaceutical Group Industry Co ranks #156 out of 958 companies for Operating Margin %. This places Joincare Pharmaceutical Group Industry Co in the top 16% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 7.24. Joincare Pharmaceutical Group Industry Co's value of 26.73% is 269.2% above this benchmark. Historically, Joincare Pharmaceutical Group Industry Co's own Operating Margin % has ranged from 11.86 to 22.55 over the past decade. While the company's 10-year median is 18.69 vs. the industry median of 7.24, Joincare Pharmaceutical Group Industry Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.24, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joincare Pharmaceutical Group Industry Co's current Operating Margin % of 26.73% is 269.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joincare Pharmaceutical Group Industry Co's current Operating Margin % is 26.73%, which is 43% above median its own 10-year median of 18.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joincare Pharmaceutical Group Industry Co stock overvalued right now?
Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co (SHSE:600380) is currently considered Fairly Valued. The stock's GF Value™ is ¥11.11, compared to a current price of ¥10.49 — trading 5.6% below its estimated fair value. The current Operating Margin % is 26.73%, which is 43% above median its 10-year median of 18.69 and 269.2% above the Drug Manufacturers industry median of 7.24. Joincare Pharmaceutical Group Industry Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Joincare Pharmaceutical Group Industry Co (SHSE:600380), the current Operating Margin % is 26.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joincare Pharmaceutical Group Industry Co (SHSE:600380) Overvalued in 2026?
Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued.
The current stock price of ¥10.49 is trading 5.6% below its estimated GF Value™ of ¥11.11.
GuruFocus considers Joincare Pharmaceutical Group Industry Co to be Fairly Valued.
Key valuation signals for SHSE:600380:
Operating Margin %: 26.73% (43% above median its 10-year median of 18.69)
GF Value™: ¥11.11 vs. price of ¥10.49 (5.6% below fair value)
Industry Position: 269.2% above the Drug Manufacturers median (#156 of 958)
No single metric tells the full story. See the SHSE:600380 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
80GF Score
Get the complete analysis for SHSE:600380
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600380 has been successfully added to your 
